Cencora prices $3.0B senior notes offering across five tranches to repay OneOncology acquisition debt

Cencora, Inc.

$3.0B aggregate of senior notes in five tranches: 2029 (3.950%), 2030 (4.250%), 2033 (4.600%), 2036 (4.900%), 2056 (5.650%).
Net proceeds (~$2.98B) to repay 364-Day Term Loan (used for OneOncology) and for general corporate purposes.
Offering expected to close February 13, 2026; joint book-runners: Citigroup, J.P. Morgan, BofA, Wells Fargo.
Offered under shelf registration filed Nov 26, 2024; underwriting agreement entered Feb 10, 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.